Clinical Trials Browser

Phase 3 × enasidenib × Clear all

NCT02577406 2025-05-18

IDHENTIFY

Phase 3 Completed

319 enrolled 29 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

NCT03839771 2024-10-02

HOVON150AML

Phase 3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute